Low Expression of the Androgen-Induced Tumor Suppressor Gene PLZF and Lethal Prostate Cancer.
Konrad H StopsackTravis GerkeSvitlana TyekuchevaYing Z MazzuGwo-Shu Mary LeeGoutam ChakrabortyWassim AbidaLorelei A MucciPhilip W KantoffPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2019)
Suppression of PLZF as a consequence of androgen deprivation may be undesirable. PLZF should be tested as a predictive marker for resistance to androgen deprivation therapy.